Immediate Impact

2 by Nobel laureates 5 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
2020 Standout
Response and Resistance to BCR-ABL1-Targeted Therapies
2020 Standout
2 intermediate papers

Works of Roberta Sala being referenced

Clinical Characteristics and Outcome of Young Chronic Lymphocytic Leukemia Patients: A Single Institution Study of 204 Cases
1999
BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase
1998

Author Peers

Author Last Decade Papers Cites
Roberta Sala 207 105 153 9 284
Binsah George 250 99 187 8 284
S. Murphy 127 122 82 13 335
I Urasiński 262 47 204 13 324
D. Janson 254 74 174 9 327
Aline Moignet 183 62 177 11 307
Takashi Kuga 49 149 63 10 314
Sara Vieira 101 157 29 14 325
Marta Ubezio 170 222 31 9 307
M J Grange 124 112 103 10 313
Lo Ann C. Peterson 178 65 143 10 307

All Works

Loading papers...

Rankless by CCL
2026